Home > Managing Myeloma in Newly Diagnosed Elderly Patients
Geriatric Oncology, Multiple Myeloma

Managing Myeloma in Newly Diagnosed Elderly Patients

Published Online: April 11th 2014

Dr. María-Victoria Mateos, a leading myeloma researcher, explores the excitement surrounding advances in the management of newly diagnosed elderly patients and the hope for a new standard of care. Dr. Mateos also provides an overview of the Phase III VISTA (Velcade as Initial Standard Therapy) trial and discusses its impact on long-term survival. Dr. Mateos explains how maintenance therapy with Velcade (bortezomib), dose and schedule modifications, and the management of adverse events are all vital factors in maximizing treatment and providing improved overall survival.

Related Videos In Multiple Myeloma
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar